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Introducllon
Recognition of antigens by T Iymphocytes requires their presentation by glycoproteins encoded in the major histocompatibility complex (MHC), a phenomenon reterred to as MHC restrlction (Schwartz, 1985) . It Is assumed that, after synthesis In infected cells, viral protein antigens have to be processed to yleld peptides that, after binding to the MHC-encoded glycoproteins expressed in those cells. are presented at the cell surface to the T cell receptor. Processing is a poorly understood event that appears to involve limited proteolytic degradation (Shimonkevitz et al.. 1983; Townsend et al.. 1985) . Antigens presented by MHC class 11 molecules are processed in 10w-pH endosomes, whereas antigens synthesized within the cell and presented by MHC class I molecules seem to be processed at a so far unknown. yet different, cytoplasmic site (Braciale et al., 1987; Germain, 1986 Germain, , 1988 . The location at which the physiological association of antigens with MHC cl ass I molecules takes place is not known either, but it has been shown that externally added antigenic peptides can be presented at the cell surface (Townsend et al., 1986) .
Viruses can intertere with antigen presentation by affecting the surface expression of cel! membrane proteins required for the recognition of infected ceUs by cytolytic T Iymphocytes (CTLs). For several viruses (Gooding, 1982; Bernards et al., 1983) , including herpesviruses (Jennings et al. , 1985; Masucci et al. , 1987) , defective antigen recognition has been associated with decreased surface levels of MHC class I glycoproteins. For adenoviruses, there is evidence that the underlying mechanism is an active interference with class I mRNA processing (Vaessen et al., 1987) or with glycosylation (Burgert and Kvist. 1985) . A correlation of these tindings with tumorigenicity and evasion of adenoviruses and SV40 from the immune response (Gooding, 1982; Bernards et al., 1983; Tanaka et al., 1985) is a matter of controversy (Haddada et al., 1988) .
For Epstein-Barr virus, evasion trom host-cellular immunity has been suggested to result from the establishment of a latent infaction in cells that. owing to very low surface levels of accessory adhesion molecules, constitute poor targets tor antiviral CTLs (Gregory et al., 1988) . As expected, and as actually shown 10r class I molecules (Yewdeli et al., 1988) , the reduction in the surface levels of cell membrane proteins required 10r antigen presentation and target cell recognition by CTLs indiscriminately prevents effieient reeognition of any antigen.
Previous observations made with murine cytomegalovirus (MCMV) infection suggest the existence of an interference of viral gene products with antigen processing and presentation that is not mediated through a modulation in the expression of MHC class I molecules. In permissive cells, cytomegalovirus (CMV) gene expression is regulated in a cascade fashion characteristic of herpesviruses (Stinski, 1983) . Proteins expressed in the immediate-early (IE) phase of infection, such as the nonstructural regula. tory phosphoprotein pp89, wh ich is eneoded by MCMV gene iel (Keil et al., 1985 Koszinowski et al., 1986) , are required tor the subsequent expression of early-phase genes, which, after onset of DNA replieation, are followed by late-phase genes. IE proteins also represent antigens recognized by the majority of antiviral CTLs Koszinowski et aI., 1987; Borysiewicz et al.. 1988) . Vaccination of mice with the recombinant vaccinia virus MCMV-iel-VAC, which expresses pp89 as the only MCMV gene produet (Volkmer et al. , 1987) , sensitizes CD8+ T Iymphocytes that protect mice against lethai challenge with MCMV (Jonjic st al., 1988) . The L d-restricted CTL clone IEl Iyses cells that selectively synthesize IE proteins (Reddehase et al.. 1986a) and is specific 10r a peptide of pp89 (Dei Val et al. , 1988; Reddehaseet al. , 1989) . Clone IEl alsorecognizes pp89 when it is synthesized again during the late phase of infaction, whereas, even though pp89 is present throughout the virus repUcation cycle, no recognition takes place du ring the early phase (Reddehase et al. , 1986b) . Because these experiments did not reveal any alteration in MHC elass I expression. an as yet unknown meehanism that prevents pp89 antigen presentation to CTLs must be postulated to operate during the early phase.
In this artiele we describe that MCMV gene products in· terfere in a very selective way with the posttranslational steps of processing and presentation of pp89 for recogni. tion by MHC cl ass I-restrieted CTLs. Unlike the inhibitory mechanisms mentioned above, the surface levels of MHC class I mOlecules, as weil as their capacity to present both externally added and other endogenously synthesized viral antigens, remain unaffeeted. The data demonstrate that the three conditions regarded as essential and sufficient tor target cell formation, namely, the presence of a sufficient amount of an antigenic protein, the funetional integrity of general processing mechanisms, and the presence of MHC molecules capable of presenting antigens, do not guarantee the recognition of that antigen by CTLs. These tindings thus reveal the existence of hitherto unknown mechanisms regulating antigen processing and presentation.
Results

Transition to the Early Phase of MCMV Gene Expression Prevents Presentation of the IE Protein pp89 to CTL Clone IEl
The kinetics of the expression of the MCMV IE protein pp89 in permissively infeeted mouse embryo fibroblasts (MEFs) have been determined previously (Keil et al., , 1985 Reddehase et al., 1986b) . Gene lei encoding pp89 is transcribed during the IE phase of viral gene expression, becomes silent during the early phase, and is transcribed again du ring the laie phase. The synthesis of pp89 and the recognition of infected MEFs by the Ld-restrieted pp89-specific CTL clone IE1 also follow essentially these kinetics (Figures la-lc; Reddehase et al., 1986b in the early phase by performing the infeetion in the presenca of phosphonoacetic acid (PAA) and tested 24 hr after infeclion (Reddehase et al., 1986b) , and also when they were tested at different limes during the early phase (data 10r 3, 5, 8,12, and 16 hr postinfeetion [p.i.] are jointly shown in Figure 1b) . The faet that infeeted cells were no longer recognized by clone IEl after only 3 hr 01 permissive inteelion suggested that viral gene products expressed during the early phase negatively affeeted the presentation of pp89.
Because the rate of pp89 synthesis is low in the physiologieallE phase, infection was per10rmed in the presence of cycloheximide (CH) to prevent translation, which results in an accumulation of IE transcripts. Enhancad and selective synthesis of IE proteins, the most abundant of which is pp89, is then accomplished by replacing CH by actinomycin D (aet D), which causes release from the translation block while preventing the transcription of early genes (see experimental design in Figure 2 , top; Reddehase et al., 1986b) . Under these conditions the synthesis 01 pp89 continues for at least 8 hr without detectable decline (Keil et 81.,1985) , and the recognition of the cells by clone IEl is markedly increased (Figure 1d ; Reddehase et 81., 1984) . 11, however, Ihe transition to early gene expression is not blocked by aet D after the removal of CH, the synthesis of pp89 from the accumulated IE transcripts declines with time (Keil et al., 1985) and the calls no longer constitute targets 10r clone IEl (Figure le ). These results demonstrate the following: first, transition to the early phase, wh ich shuts off IE translation, also prevents the expression of the antigenie determinant of pp89 defined by clone IE1; second, this prevention is posttranscriptional; and third, It cannot be overcome by enhancing the transcription of IE genes.
Since pp89 can be deteeted with specific antibodies throughout the early phase, the data were thus far consistent with the interpretation that recognition of the antigen by clone IE1 correlated with the synthesis of pp89 rather than with its presence (Reddehase et al., 1986b) . The early phase lasts about 16 hr, du ring which transcription from the entire 235 kb genome, involving a high number of genes, is deteeted (Keil et a1., 1984) . None of these genes is defined as yet. Viral funetions that cause the shutoff of pp89 synthesis and those that prevent the presentation of the IEl determinant may be speci1ied by the same gene or by different genes. In addition to early gene 1unetions, an autoregulatory role of pp89 in antigen presentation has to be considered. To disseet these events, the experimental regimen explained in Figure 2 (bottom) was employed: by adding act D not immediately after removal of CH but at defined time points later, a variable period permissive for early gene transcription was set. With this approach it was determined that an interval of 20 min of early gene transciption was sutficient to diminish the presentation of the pp89 antigen, and that an interval of 45 min completely interfered with it ( Figure 3a ). It has been demonstrated that pp89 can aetivate the transcription of cellular genes such as c..fos (Schickedanz et al., 1988) . During the interval permissive tor early gene transcription, the pp89 synthesized in the absence of aet D could aetivate the transcription not only of viral early genes but also of cellular genes. Therefore, the possibility had to be considered that the inhibitory effeet on pp89 antigen presentation was caused by cellular proteins induced by pp89. The same schedule of treatment with the metabolic inhibitors of the trans1ectant cell line Uiel-L d, which expresses pp89 constitutively, as weil as of MEFs infected with the recombinant virus MCMV-ie/-VAC, which expresses pp89 only upon infection, and both of which lack MCMV early genes, did not prevent or reduce lysis by CTLs (Figures 3b and 3c ). These controls thus excluded the possibility that cellular proteins induced by pp89 itsel1 or by related proteins translated from splicing derivatives in transcription unit ial were responsible for the failure in pp89 antigen expression. In conclusion, the 1unetion that interferes with processing and presentation of the pp89 antigen is based on viral genes expressed in the first 45 min after transition to the early phase.
Inhibition of pp89 Antigen Preaentatlon and of pp89 Synthesls Are Separate Events pp89 is not a struetural component of the virus particle; therefore, its synthesis in infected cells is required for recognition by pp89-specific CTLs. It was an open question whether the genes expressed during the first 45 min of the early phase, which abrogate pp89 antigen presentation, also caused the shutoff 01 pp89 synthesis or whether this effect was specified by genes expressed at later times during the prolonged early phase. To this end, protein synthesis after periods of 20 and 45 min of early gene transcription was analyzed by pulse-Iabeling and immunoprecipitation al 5, 7, and 9 hr p.L, Le., after 2,4, and 6 hr of translation. No difference was found at any time tested in the rate of synthesis of pp89 between cells expressing only JE genes (Figura 4A, Jane b) and those that also express early genes (Ianes c and d). Shown are only the data for 9 hr p.i., the time point that coincides with the end of the cytolytic assay. Posttranslational conversion 01 pp89 to pp76, which is mediated by cellular proteases (Keil et al., 1985) , was not altered either. The only difference detected after immunoprecipitation between cells Iysed by CTL clone IEl (Iane b) and those not recognized was the additional presence of early proteins (marked with E in Figure  4A , lanes c and d). These results indicated that the genes that negatively affeet pp89 synthesis are not transcribed during the first 45 min of the early phase. It is worth noting that in spite of a significantly lower rate of pp89 synthesis in Uiel-L d transfectants (Iane e), these cells are efticiently recognized by CTLs. The experimental dissection of the interference with pp89 antigen presentation and the down-regulation of pp89 synthesis proved that these are separate events operating at different times du ring the early phase. In addition, it was concluded from these data that the inhibitory efteet on pp89 antigen presentation operates posttranslationally. ( Townsend et al. , 1988) . This further strengthened the idea that processing of an antigen involves proteolytic degradation (Townsend et al., 1985 (Townsend et al., , 1986 . Following this reasoning, an increased stability of pp89 during the early phase could offer an explanation for the observed lack of recognition by CTLs. On the other hand, a different cleavage pattern of pp89 during the early phase might lead to the destruction of the epitope recognized by CTLs, and this would also result in a failure of antigen presentation. Therefore, the stability of pp89 during the IE and early phases was compared. As a first step, the amount of pp89 synthesized after release from the CH block and present in infected cells at 5, 7, and 9 hr p.i. was measured by Western blot analysis in ceUs expressing only IE proteins and in cells also expressing early proteins. As shown in Figure 4B for 9 hr p.i., the amount of IE proteins was the same regardless of whether early genes were expressed (compare lane b with lanes c and d) and was clearly higher in infected (Ianes b-d) than in transfected cells (Iane e). As a second step, the stability of pp89 under IE and early conditions was measured by pulse-Iabeling with psSlmethionine at 3 hr p.i. followed by aperiod of chase in the absence of radioactive precursor ( Figure 5 ). With the aim of identifying the relevant protein fragments containing the IEl epitope, an antiserum raised against the 19 amino acid peptide of pp89 that contains this epitope (Dei Val et al., 1988) was used for immunoprecipitation. Even though efficiently presented to CTLs, pp89 synthesized in the IE phase represents a very stable protein, since most of the labeled pp89 was still detectable in the ceUlysates even after 12 hr of chase ( Figure 5 , 1L, lanes a-d). The same stability was observed for pp89 when transcription was allowed for 45 min ( Figure 5 , 2L, lanes a-d). Low amounts of proteins smaUer than pp89 that contained the IE1 epitope were detected. These might represent either degradation products or proteins related to pp89 and arising by differential splicing from transcription unit ie1, which encodes pp89 (Keil et al. , , 1985 . The protein pattern was the same under IE or early conditions, and was also identical with the one detected when, instead of the epitope-specific antiserum, antiserum directed against the whole protein was used (data not shown), thus giving no indication of a selective destruction of the IE1 epitope. However, relevant fragments of small size or very low abundance may have passed undetected. The same results were obtained when radioactive labeling was performed at 6 hr p.i. (data not shown). Altogether, these findings demonstrated that MCMV early gene expression was not associated with an alte red stability of pp89. After synthesis, pp89 migrates into the nucleus, where it activates transcription (Koszinowski et al., 1986) . From a deletion mutant of pp89 that lacks the nuclear transport signal and is therefore confined to the cytoplasm, it is known that migration of pp89 into the nucleus is not required for recognition by CTLs (H. Volkmer and M. O. v., unpublished data) . This finding is in accordance with the widely accepted idea (Germain, 1988 ) that processing of endogenously synthesized antigens takes place in a cytoplasmic compartment. On the other hand, enhanced In summary, neither a general enhancement of pp89 stability, nor a detectable selective loss of the epitope, nor a different nuclear/cytoplasmic compartmentalization of the protein can account for the lack of pp89 antigen presentation to CTLs in the early phase.
The Fate of the IE1 Epltope Reflects the Recognltlon of pp89 by BALBIc Polyclonal CTLs The data presented so far showed that the particular epitope of pp89 defined by clone IE1 was no longer detectable when viral gene expression proceeded into the early phase. To study whether the fate of this epitope was representative of the recognition of all pp89 epitopes, pp89 presentation to BALBIc pp89-specific polyclonal CTLs was analyzed. By using MCMV-ie/-VAC for in vivo sensitization, pp89-specific polyclonal CTLs were generated that recognized cells arrested in the IE phase of MCMV infection (Figure 6a) . Transition into the early phase prevented recognition of pp89 by these polyclonal CTLs with kinetics indistinguishable from those observed for clone IEl (Figures 6b-6d ). In addition, it was found that pp89-specific polyclonal CTLs did not Iyse infected fibroblasts of the mutant strain BALB/c-H-2d m2 , in wh ich the L d gene is deleted (Table 1 B) . These results demonstrated that recognition of pp89 by BALB/c polyclonal CTLs was entirely restricted through Ld, the same class I moleeule that serves as the antigen-presenting molecute for clone tEl.
In conclusion, the epitope recognized by clone lEi truly reflected the recognition pattern of pp89 by polyclonal BALB/c CTLs.
Surface Expression and Functional Integrity of the MHC Class I Molecule L d during the Early Phase
For recognition by CTLs of viral antigens synthesized in an infected cell, antigenic peptides have to be presented by MHC-encoded class I glycoproteins. Interference with the cell surface expression of class I molecules can diminish or even abolish recognition by CTLs. Cytofluorometric determination of the surface expression of the MHC class I molecules Kd, Dd, and L d revealed no differences between cells that selectively synthesized JE proteins (Figure 7A , top panel), celts with restricted expression of earty genes (center panel), and uninfected cells (bottom panel). When L d served as a target antigen in a cytolytic assay using the Ld_Specific CTL clone B6aLd, no differences in target cell susceptibility to lysis were seen either ( Figure  7B ). It was thus concluded that inhibition of pp89 presentation was not associated with alterations in the surtace expression of class I molecules.
Vet, these results did not exclude an alteration in the function of the class I molecules to serve as antigenpresenting molecules, It has been proposed that incubation of target cells with peptides circumvents the intracellular steps of processing, since it leads to target cell recognition by CTLs (Townsend et al., 1986) . The synthetic nonapeptide VPHFMPTNL (one-Ietter code), which is deduced from the pp89 sequence, represents the optimal antigenie peptide tor CTL clone IE1 (Reddehase et al., 1989) . Incubation with this nonapeptide of cells that expressed MCMV early genes and did not present endogenously synthesized pp89 reveated that these cells ware still able to present the externally added nonapeptide ( Figure 7C , center panel). Identical resutts with the suboptimal heptapeptide PHFMPTN confirmed this conclusion (data not shown). Therefore, the block in pp89 presentation was caused neither by an alteration in the cell surface expression of L d nor by a defect in its function to present antigenic peptides. 
Selectlvity of the Negative Regulation of pp89 Antigen Processlng and Presentation
From all these findings It can be eoneluded that the Interferenee with pp89 antigen expression involved the poorly defined intraeellular steps of the antigen-proeessing and -presentation pathways. To study whether this negative regulation is selective tor pp89 or eoneerns antigen presentation in general, the effect on the presentation of other MCMV antigens expressed concomitantly with pp89 was analyzed (Table 1) . To this end, CTLs derived from infected mice were cloned and screened tor recognition of cells infected with MCMV in the presence of PAA. Viral gene expression in such cells is restricted to IE and early genes, and, although they are not recognized by CTL clone IE1, they constitute targets for polyclonal MCMVspecific CTLs . With this approach, two new CTL clones were established, E1 and E2, both of which recognized MCMV early antigens since they were able to Iyse cells infected in the presence of PAA but did not recognize cells infected under IE conditions (Table  1A) . Antigen recognition by both clones was restricted through Ld, since no lysis of infected BALB/c-H-2<'m2 cells, which lack L d, was detected ( Bühler et al. , unpublished data) , which indicated that these two CTL clones have different antigen specificities (Table 1C) . Lysis of infected cells by clones E1 and E2 was not higher during the late phase than du ring the early phase (not shown). The objection that presentation of E1 and E2 antigens might also have been inhibited during the early phase, although to a lower extent than pp89, can thus be refuted. Presentation of these two antigens could account for the recognition of early-phase infected cells by polyclonal MCMV-specific CTLs (Table 1A) ; however, additional viral antigens must be presented during the early phase by the Kd or Od glycoproteins, beC8use BALBlc-H-2 dm2 cells infected in the presence of PAA were also recognized by these polyclonal CTLs (Table 1B) . It was therefore concluded that, even though presentation of pp89 to BALBlc CTLs was prevented du ring the early phase. presentation of at least three other viral antigens, two of them L d restricted, as is pp89 itself, was nevertheless very efficient. When recognition of MCMV-infected cells by C57BU6 (H-2 b ) pp89-specific polyclonal CTLs was analyzed, it was found that, as was the case in the H-2 d haplotype, presentation of pp89 by H-2 b cl ass I molecules did occur during the IE phase but was prevented during the early phase (Table 10) . Again, the testing of MCMV-specific polyclonal CTLs revealed further viral antigens presented during the early phase by H-2 b class I molecules (Table  10) .
COllectively, the results summarized in Table 1 demonstrate that the inhibitory effect on pp89 antigen presentation is highly selective, because at least two viral early antigens presented by L d, at least one presented by Kd or Od, and at least one presented by Kb or Ob were not subiect to this inhibition. A general block aftecting processing and presentation of all nascent viral antigens in the early phase of MCMV replication was thus excluded. same MHC class I molecule and recognized by CTLs can be demonstrated with synthetic peptides (Maryanski et al. , 1987) . In particular, it has been recently shown that peptides derived from the tum-antigen P91A (Oe Plaen et al., 1988 ) and pp89-derived peptides, the only two antigenic sequences presented by the L d glycoprotein that have been charaeterized so tar, can mutually compete for L d (Lurquin et 81., 1989) . Ouring the early phase of infection, when the IE protein pp89 is not presented by Ld, other antigens are recognized by the Ld-restricted CTL clones E1 and E2. Competition tor the L d molecule e1-feeted by these early antigens could possibly prevent presentation of pp89 du ring the early phase.
Inhibition of pp89 Presentation Cannot
To test this hypothesis, the kinetics of pp89 and E1 antigen expression were analyzed during the transition trom the IE to the early phase. The duration of early gene transcription was limited by the addition of aet 0 at different times after removal of CH, in order to detect the time at which the earty gene encoding the El antigen is ex- Figure 8A indicate that 2-4 hr of early gene transcription was required eventually to obtain an amount of El antigen sufficient for deteetion by CTL clone E1. This period 01 early gene transcription was longer than the period required to prevent pp89 antigen presentation, thus suggesting that E1 peptide competition for L d was unlikely. It could be argued, however, that the amount of El peptide required for competition with pp89 is lower than the amount required for target recognition by CTL clone E1. This possibility was excluded by the finding that simultaneous presentation of pp89 and E1 took pi ace in the late phase of the virus replication cycle ( Figure 8B ). Recognition of infeeted cells by CTL clone E2 also oecurred during the late phase (data not shown). Thus, sufficient amounts of E1 and E2 peptides were present in the late phase to produce a target; nevertheless, they did not exert an inhibitory effect on the presentation of pp89-derived peptides.
pressed. The results shown in
In summary, the seleetive prevention of pp89 antigen presentation that occurs during the early phase of the MCMV replication cycle cannot be explained by competition for binding to the L d molecule exerted by the endogenously synthesized viral antigens E1 and E2.
Discusslon
In response to infection with MCMV, BALBJc mice generate proteetive T Iymphocytes of the C08+ subset. These T Iymphocytes predominantly recognize antigens synthesized during the IE phase of the viral replication cycle. Vaccination with the recombinant vaccinia virus MCMVlel-V AC, encoding the major IE protein pp89, renders mice rasistant to lethai challenge with MCMV. By using both polyclonal and cloned pp89-speeific MHC class I (Ld)-restricted CTL lines, regulation of the presentation of pp89 was examined throughout the virus replication cycle. We present evidence 10r the following: first, similar to MCMV gene expression, which is temporally regulated in three phases-namely, IE, early, and late-pracessing and presentation of pp89 for recognition by CTLs is under strict contral, displaying the same kinetics; second, arrest of the viral replication cascade in the IE phase, as weil as selective expression of the isolated gene iel encoding pp89, provide efficient antigen presentation; third, release trom the arrest followed by expression of the first viral early genes completely prevents pp89 antigen presentation; fourth, the late phase of gene expression is associated with reinitiation of pp89 synthesis and release from the interference with antigen presentation; fifth, the interference with pp89 antigen presentation occurs posttranslationally but does not involve alterations in protein amount, stability, or nuclear compartmentalization; sixth, the surface expression and antigen-presenting function of the MHC class I molecule Ld are not affected; and seventh, the intervention with pp89 antigen processing and presentation is highly selective in that it does not apply to other MCMV antigens synthesized concomitantly with pp89 in the infected cells and presented by several different class I molecules, including Ld.
This report gives a clear example for a highly selective, temporally regulated, and reversible prevention of viral antigen presentation to elass I-restricted T Iymphocytes. The results indicate that the interference takes place at an intracellular stage of pp89 antigen processing after translation and before the presentation of antigenic peptides at the cell surface.
Because of its selectivity, the inhibition of pp89 presentation is unlike other reported cases of interference with antigen recognition by CTLs, all of which could be explained by a general decrease in the surface levels of ce 1-lular presenting or adhesion moleeules (Gooding, 1982; Bernards et al. , 1983; Jennings et al., 1985; Masucci et al. , 1987; Gregory et al.. 1988 ) that indiscriminately affects the presentation of any antigen.
An observation more closely related to the data presented in this article has been made in recombinant vaccinia virus-infected cells. in which presentation of influenza virus antigens to CTLs was influenced by the phase of vaccinia virus gene expression (Coupar et al. , 1986) . DurIng the late phase of the virus replication cycle, and to some extent also during the early phase, partial or total inhibition of presentation of several influenza virus epitopes was observed (Townsend et al., 1988) . Vaccinia virus-induced shutof1 of cellular functions was discussed as a possible mechanism of the inhibition of antigen presentation. Beeause restoration of antigen recognition could be achieved by reducing the stability of influenza proteins, it was proposed, as an alternative explanation, that putative protease inhibitors encoded by vaccinia virus might be responsible for the observed inhibition of antigen processing.
Besides the replication-phase association, the inhibitory effect observed here for MCMV has little in common with the inhibitory effect described for vaccinia virus, and the mechanisms postulated there may not apply. First, MCMV does not induce a strong host shutoff, in particular not at the beginning 01 the early phase. Second, in comparison with the IE phase, when pp89 presentation was optimal, no alterations in pp89 stability were observed during the early phase, when presentation was blocked. For teehnicaJ reasons, an MCMV recombinant expressing an unstable pp89 has not been constructed to date. If, as the data presented by Townsend et al. (1988) convincingly suggest, the rate of protein degradation governs antigen processing, then an accelerated catabolism of pp89 resulting in its processing before the inhibitory function has had time to operate would restore antigen presentation in cells infected with such an MCMV recombinant. This, however, would not explain the mechanism 01 interference with pp89 presentation. Third, the highly selective nature of the inhibition of pp89 antigen presentation is not compatible with the more general eftect of protease inhibitors. Recently the human CMV, a virus closely related to MCMV, has been completely sequenced. Comparison of open reading frames coding 10r polypeptides of 300 amino acids and larger with available data bases has, unlike the example of vaccinia virus (Kotwal and Moss, 1989) , revealed no detectable homology to known serine protease inhibitors (B. G. BarrelI, personal communication). In summary, as opposed to the vaccinia virus system, a meehanism ot inhibition that selectively aftects pp89 must be proposed for MCMV. An alternative mechanism that we considered is competition at the peptide level tor binding to the Ld molecule. Related pp89-derived synthetic peptides, differing only in length and a11 containing the antigenic core sequence HFMPT, differ considerably in their antigenic potency, with the nonapeptide YPHFMPTNL having a very high affinity tor Ld (Reddehase et al., 1989) . Since it is not known which ot these peptides are actually generated in infeeted cells, it is highly possible that peptides derived from the early antigens E1 and E2 have a higher affinity for L d. However, because simultaneous recognition of pp89, E1, and E2 was feasible in the late phase, peptide competition exerted by E1 or E2 is not a likely meehanism. It can be expeeted that, if pp89 were competed out by an unknown competitor stronger than E1 and E2, this competitor should also compete with E1 and E2. From all this, it appears that the number of L d molecules available for binding of peptides is not the limiting factor tor pp89 presentation. Finally, the fact that the inhibitory effect operated also in the H-2 b haplotype, in which the antigenic determinants of pp89 and of early antigens are most probably different trom those presented by Ld, also disfavors competition.
In view of the evidence available, we hypothesize that inhibition of pp89 presentation is caused by a selective effect on pp89 exerted during the early phase by a viral protein or by a cellular factor induced by it. The selectivity of the effeet may relate to the regulatory function of pp89. As a mechanism, one could imagine complex formation with pp89 or an enzymatic activity exerted on pp89, either of which could prevent correct processing or transport 10 the cell surface. Studies with mutated pp89 may help to identify possible target sequences for the proposed interactions, and analysis of the genes transcribed during the first period of the early phase should contribute 10 the understanding of the underlying mechanism.
An interesting impUcation of our results is the fact that abundant expression of a protein of proven antigenicity in cells that express all molecules essential for antigen processing and presentation does not inevitably result in presentation of this antigen. It is worth considering that the presentation of certain cellular protein antigens may be subject to similar control mechanisms. Such regulatory mechanisms could add considerably to the complexity of self/nonself discrimination.
Under the control of the immune system, CMV persists for life in the infected host in astate of latency that is associated with a block in viral gene expression, a characteristic of herpesviruses. For human CMV there is evidence that IE genes, but not late genes, are expressed in latently infected cells (Rice et al. , 1984; Schrier et al., 1985) . Since in human CMV the gene IE1 corresponding to gene iel of MCMV also codes for an immunodominant antigen for CTLs (Borysiewicz et al., 1988) , it remains an unsolved question how latently infected cells expressing a protein of proven antigenicity can survive in the face of a specific CTL response. The kind of negative regulation of antigen presentation documented here for MCMV could provide the solution for this paradox.
Experimental Pl'OOedures Mice BALBIc mice (H-2 d haplotype), BALB/c-H-~m2 mutant mice lacking Ld (Hansen et al., 1977) . and C57BLJ6 mice (H-2 b haplotype) ware bred in our own colony under specific-pathogen-free conditions. Cells and Vlruses Third-passage MEFs were used for virus inlection. The LJL d line of L fibroblasts (H-2 k haplotype). which is transfected with the gene for the MHC class I moleeule L d. and the LJie1-L d line, which is transfected in addition with MCMV transcription unit ie1. have been described previously (Koszinowski et aI., 1987) . MCMV of the strain Smith  American Type Culture Collection. Rockville, MD) was employed as tissue-culture-grown virus. The production of the recombinant vaccinia virus MCMWe/-VAC. enCQding pp89. has been reported before (Volkmer et aI., 1987) .
Cytolytlc Effector Cella Generation 01 MCMV-specifie and pp89-specilic polyclonal CTLs was achieved by in vitro restimulation with MCMV 01 spleen cells from mice that ware latently infected with MCMV and inlected with 1 x 10S PFU of MCMV-iel.llAC 3 weeks before, respectively (Dei Val et aI .
• 1988).
The L d-restricted pp89-specilic CTL clone IE1 (Reddehase et al.. 19B6a, 1989 ) and the L d..specific CTL clone B6o.L d (Reddehase et al., 1986b) have been eharacterized previously. The l d-restricted CTL clones E1 and E2. whieh are specific for MCMV early antigens, ware cloned by limiting dilution from MCMV-specific polyclonal CTL cul· tures. Clones El and E2 ware grown In medium contalning 100 U/ml recombinanl human interleukin 2 (Sandoz Forschungsinstitut, Vienna. Austria), and restimulated weekly with MCMV and stimulator cells as described for clone IE1 (Reddehase st al., 1986a) .
Target Cella and Cytolytlc Anaya For selectiVe and enhanced expression ollE genes, MEF ware infected with 0.5 PFU of MCMV per cell by centrifugation (800 x g, 30 min), which results in a multiplicity of infection 0110-20 . Inlection was performed in the presence 01 CH (50 ",gImi). which was removed 3 hr later by washing with medium containing act 0 (5 I1glml). limited early gene transcription alter the CH treatment was achieved by removal of CH using inhibitor-free medium and byadding act 0 to the final concentration of 5 I1g1ml after the intervals indicated. The same metabolie inhibitor treatment was performed on Uie1-L d eells. Inlection of MEF with MCMWe/-VAC was done as with MCMV except that a multiplicily of 3 was used.
Restriction 01 gene expression 10 the IE and early phases of the MCMV replication cycle was achieved by infecting MEF with MCMV in the presence 01 PAA (250 l1g1ml) 10 prevent viral ONA replication and late-phase gene expression.
Target cells ware trypsinized and labeled for 90 min with Na251Cr04. and a standard 3 hr cytoIytic assay was performed with 1000 target cells and graded numbers of effector cells in 2-fold dilution steps. Oata represent Ihe mean percentage of specific lysis from three replicate cultures. For preparing !arge! cells with exogenously added peptides, cells ware incubated with peptides al a concenlration 01 100 11M for 1 hr at 37"C after the 51Cr labeling, followed by removal 01 excess peptide by washing the target eells before the addition of effector cells.
Immunoprecipltation and Western Blot Analysis
Experiments were performed essentially as described (Keil el al. , 1985) . In brief, the same number of Uie1-l d cells. uninlected MEF. and MEF infected with MCMV under the same conditions as used lor target cell preparalion ware labeled with [35S)methionine in methionine-free medium for 20 min, starting al 5, 7. and 9 hr p.1. Ceillysates were immunoprecipitated with a murine antiserum 10 MCMV and anaIyzed by 10% polyacrylamide gel electrophoresis and autoradiography. Western blot analysis was performed wilh the same Iysates. which, after separation by electrophoresis. ware blotted onto a nitrocellulose membrane and incubated with the same antiserum.
Pulse-Labellng, Chase, and NuclearlCytoplasmlo Fractionation Uninfected MEFs and MEFs infected with MCMV In the presence of CH ware trypsinized at 3 hr p.i., that iso immedietely after CH removal. and labeled with [35Slmethionine for 30 min in medium devoid of unlabeled methionine. Ac! 0 was added at the indicated times. After the labeting period, cells were washed twiee with medium containing a 2QOO..foId excess of unlabeled methionine, followed by further incubation in medium containing the standard concentration of methIonine. At given time points, atiquots ware taken for the preparetlon of wholeceillysales and tor the seperation of nuclear and cytoplasmic fractions (Keil et al., 1985) . This separation was achieved by resuspending the sedimented cells for 5 min in ice-cold buffer I (10 mM Trls-HCI (pH 8.51. 0.14 M NaCl. 1.5 mM MgC1 2 , 0.5% Nonidel P-40), foIlowed by centrifugation (800 x g, 4"C. 5 min) Ihrough a cushion of 24% sucrose in bufler I. Lysates ware then prepared trom the cytoplasmic frection on top of the cushion and from the sedimented nuclei. lysates ware anaIyzed by immunoprecipitation and gel electrophoresis. A rabbit antiserum raised agalnst the synthetic peptide p(161-179) of pp89 coupled 10 bovine serum albumin as descrlbed (Dei Val et al., 1988) was used lor immunoprecipltation.
Flow Cytofluorometry Uninfected MEFs and MCMV-infected MEFs ware trealed with CH and act 0 foIlowing the protocol for target cell preperatlon. They ware then incubated with the monoclonal antibodies 822-249 (Lemke et al.. 1979),34.5.88, and 31.3.48 (Cachet et aI .• 1986) , specific for Ld, [)d. and K". respectively, followed by fluorescein-conjugeted (F(ab'k fragments of goal anti-moose IgG antibodies (Jackson Immunoresearch laboratories lne., West Grove. PA) and analyzed on a FACS IV as dascribed (Reddehase et at .• 19B6a) . payment 01 page charges. This article must therefore be hereby marked "8dvertlsement" in accordance with 18 U.S.C. Section 1734 solely to indiesle this fact.
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